Lysosomal alpha-glucosidase — Drug Target

All drugs that target Lysosomal alpha-glucosidase — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

voglibose · Glucosylceramide Synthase Inhibitor [EPC] · alpha-Glucosidase Inhibitor

Marketed (3)

• Glustat · voglibose · Metabolic
• Zavesca · AstraZeneca · Glucosylceramide Synthase Inhibitor [EPC] · Metabolic
  Zavesca works by inhibiting the enzyme glucosylceramide synthase, which is involved in the production of a toxic lipid that accumulates in cells of patients with certain lysosomal storage disorders.
• Glyset · Pfizer · alpha-Glucosidase Inhibitor · Metabolic
  Glyset works by delaying the breakdown of carbohydrates in the gut, allowing less glucose to enter the bloodstream.